APA

Ummenthum K., Peferoen L. A. N., Finardi A., Baker D., Pryce G., Mantovani A., Bsibsi M., Bottazzi B., Peferoen-Baert R., van der Valk P., Garlanda C., Kipp M., Furlan R., van Noort J. M. & Amor S. (20160804). Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease. : European journal of immunology.

Chicago

Ummenthum Kimberley, Peferoen Laura A N, Finardi Annamaria, Baker David, Pryce Gareth, Mantovani Alberto, Bsibsi Malika, Bottazzi Barbara, Peferoen-Baert Regina, van der Valk Paul, Garlanda Cecilia, Kipp Markus, Furlan Roberto, van Noort Johannes M and Amor Sandra. 20160804. Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease. : European journal of immunology.

Harvard

Ummenthum K., Peferoen L. A. N., Finardi A., Baker D., Pryce G., Mantovani A., Bsibsi M., Bottazzi B., Peferoen-Baert R., van der Valk P., Garlanda C., Kipp M., Furlan R., van Noort J. M. and Amor S. (20160804). Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease. : European journal of immunology.

MLA

Ummenthum Kimberley, Peferoen Laura A N, Finardi Annamaria, Baker David, Pryce Gareth, Mantovani Alberto, Bsibsi Malika, Bottazzi Barbara, Peferoen-Baert Regina, van der Valk Paul, Garlanda Cecilia, Kipp Markus, Furlan Roberto, van Noort Johannes M and Amor Sandra. Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease. : European journal of immunology. 20160804.